Literature DB >> 9135731

Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

H L Davis1, C L Millan, S C Watkins.   

Abstract

DNA-based immunization of mice by intramuscular injection of antigen-encoding plasmid DNA results in immune responses which may be sustained for extended periods of time without an antigen boost. For example, we have previously shown that a strong humoral response against hepatitis B virus surface antigen (HBsAg) will persist for up to 74 weeks following a single intramuscular administration of DNA. It has been proposed that the longevity of the response is due to sustained expression of antigen in transfected muscle cells. However, here we show by immunohistochemistry and electron microscopy that HBsAg-expressing muscle fibers are destroyed around 10 days after injection of DNA in mice. We have also evaluated destruction of the transfected muscle fibers indirectly, by measurement of luciferase activity in muscles at different times after injection of a luciferase reporter gene construct, alone or in combination with HBsAg-expressing DNA. Control muscles injected with luciferase-expressing DNA alone maintain expression of high levels of luciferase for at least 60 days. In contrast, muscles co-injected with DNAs expressing luciferase and a secreted form of HBsAg show high levels of luciferase activity at 5 days but > 99% of this is lost by 20 days. Similar results are obtained with co-expression of luciferase and beta-galactosidase, a non-secreted antigen. Loss of luciferase expression does not occur in muscles of mice with severe combined immunodeficiency, indicating that the myofiber destruction is immunologically mediated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135731     DOI: 10.1038/sj.gt.3300380

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  29 in total

1.  Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.

Authors:  D E Hassett; J Zhang; M Slifka; J L Whitton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  The safety and longevity of DNA vaccines for fish.

Authors:  T Kanellos; I D Sylvester; A G Ambali; C R Howard; P H Russell
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

Review 3.  The role of CpG in DNA vaccines.

Authors:  M J McCluskie; R D Weeratna; H L Davis
Journal:  Springer Semin Immunopathol       Date:  2000

4.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

Authors:  S Zucchelli; S Capone; E Fattori; A Folgori; A Di Marco; D Casimiro; A J Simon; R Laufer; N La Monica; R Cortese; A Nicosia
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes.

Authors:  Kyle A Garver; Carla M Conway; Diane G Elliott; Gael Kurath
Journal:  Mar Biotechnol (NY)       Date:  2005-07-22       Impact factor: 3.619

7.  Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis.

Authors:  John R Greenland; Ralf Geiben; Sharmistha Ghosh; William A Pastor; Norman L Letvin
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

8.  CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Nico van Rooijen; Avi-Hai Hovav; Norman L Letvin
Journal:  Blood       Date:  2008-09-10       Impact factor: 22.113

9.  CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

Authors:  C L Brazolot Millan; R Weeratna; A M Krieg; C A Siegrist; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 10.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.